Search Results - Shirish M. Gadgeel

Refine Results
  1. 1
    Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer

    Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer by Misako Nagasaka, Shirish M. Gadgeel

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Racial differences in lung cancer.

    Racial differences in lung cancer. by Shirish M. Gadgeel, Gregory P. Kalemkerian

    Published 2003
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Modern Staging of Small Cell Lung Cancer

    Modern Staging of Small Cell Lung Cancer by Gregory P. Kalemkerian, Shirish M. Gadgeel

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    MET/HGF pathway activation as a paradigm of resistance to targeted therapies

    MET/HGF pathway activation as a paradigm of resistance to targeted therapies by Brian Ko, Tianfang He, Shirish M. Gadgeel, Balázs Halmos

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives

    Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives by Joy Tang, R. Salama, Shirish M. Gadgeel, Fazlul H. Sarkar, Aamir Ahmad

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

    Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells by Ma'in Y. Maitah, Shadan Ali, Aamir Ahmad, Shirish M. Gadgeel, Fazlul H. Sarkar

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

    Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines by Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Antoinette J. Wozniak, Fazlul H. Sarkar

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinum Refractory Non-small Cell Lung Cancer (NSCLC)

    Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinu... by Shirish M. Gadgeel, John C. Ruckdeschel, Elisabeth I. Heath, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Antoinette J. Wozniak

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data

    Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data by Manish Thakur, Julie J. Ruterbusch, Ann G. Schwartz, Shirish M. Gadgeel, Jennifer Beebe‐Dimmer, Antoinette J. Wozniak

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer

    Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer by Aliccia Bollig‐Fischer, Wei Chen, Shirish M. Gadgeel, Angela S. Wenzlaff, Michele L. Coté, Ann G. Schwartz, Gerold Bepler

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs

    Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs by Aamir Ahmad, Ma'in Y. Maitah, Kevin R. Ginnebaugh, Yiwei Li, Bin Bao, Shirish M. Gadgeel, Fazlul H. Sarkar

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic Profiling

    Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic Profiling by Angel Qin, Adrienne Johnson, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Alexa B. Schrock, Shirish M. Gadgeel

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility

    Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility by Chan Yeu Pu, Christine M. Lusk, Christine Neslund‐Dudas, Shirish M. Gadgeel, Ayman O. Soubani, Ann G. Schwartz

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival

    Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival by Jennifer Beebe‐Dimmer, Jon P. Fryzek, Cecilia Yee, Tapashi Dalvi, David H. Garabrant, Ann G. Schwartz, Shirish M. Gadgeel

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study

    Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study by Patricia LoRusso, Anthony F. Shields, Shirish M. Gadgeel, Ulka N. Vaishampayan, Tina Guthrie, Thomas A. Puchalski, John Xu, Qi Liu

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data

    Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data by Priscila Gonçalves, Stephanie Peterson, Fawn D. Vigneau, Ronald Shore, William Quarshie, Khairul Islam, Ann G. Schwartz, Antoinette J. Wozniak, Shirish M. Gadgeel

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women

    Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women by Ann G. Schwartz, Michele L. Coté, Angela S. Wenzlaff, Alison L. Van Dyke, Wei Chen, John C. Ruckdeschel, Shirish M. Gadgeel, Ayman O. Soubani

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials

    Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials by Julien Mazières, Achim Rittmeyer, Shirish M. Gadgeel, Toyoaki Hida, David R. Gandara, Diego Cortinovis, Fabrice Barlési, Wei Yu, Christina Matheny, Marcus Ballinger, Keunchil Park

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up

    Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow... by Shirish M. Gadgeel, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz‐Ares

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer

    Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer by Vinita Singh‐Gupta, Michael C. Joiner, L. Runyan, Christopher K. Yunker, Fazlul H. Sarkar, Stephen R. Miller, Shirish M. Gadgeel, André Konski, Gilda G. Hillman

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: